Home Immunocore completes $320 million (A 205 million) private financing round
 

Keywords :   


Immunocore completes $320 million (A 205 million) private financing round

2015-07-16 15:48:23| Biotech - Topix.net

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor based biological drugs to treat cancer, viral infections and autoimmune disease, today announced the completion of a US $320 million private financing round. The oversubscribed round includes new investors, Woodford Investment Management, Malin Corporation plc, Eli Lilly and Company and RTW Investments, as well as a number of new and existing investors in Immunocore.

Tags: private million round financing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »